The life expectancy of patients with hepatic ascites is uncertain and is related to the cause of the hepatic ascites, the clinical stage, the efficacy of treatment, and the physical condition. The earlier the diagnosis and the earlier the treatment, the better. The 5-year survival rate for hepatic ascites does not exceed 50%. If liver ascites is in early stage and mild, it may be better recovered after actively controlling the primary disease. If cirrhotic ascites is more serious, such as combined infection, it may have an impact on life expectancy, with a 5-year survival rate of no more than 50%. Hepatic ascites indicates that the liver function has entered the decompensated stage and developed to a more serious stage. If ascites is present in liver cancer, most life expectancy is around one year. If the ascites is caused by hepatitis B or C, the liver function is more stable and the life expectancy is longer. If gastrointestinal bleeding and hepatorenal syndrome occur, life can be jeopardized at any time. Hepatic ascites should be actively treated for the cause of the disease, hepatitis B and C need to be actively antiviral treatment, and liver cancer should be surgically resected or interventional therapy to try to prolong life. Hepatic ascites is a more serious disease, must go to the regular hospital gastroenterology active treatment to improve the prognosis.